Firm
Philosophy
Commendations
Memberships
History
Technologie
Overview
Mechanical Engineering
Automation and Robotics
Physics
Electrical Engineering, Electronics and Semiconductors (EE)
Information and Communication Technology (ICT)
New Digital Technologies
Medical Engineering
Green Technologies
Materials Science
Chemistry
Pharma
Biotechnology
Practice
Overview
Patent and Utility Model Protection
Opposition and Appeal Proceedings
Patent Infringement and Nullity Proceedings
Trademarks and Labels
Design Protection
Employee Invention Law
IP Contracts and Licenses
IP Due Diligence
Competition and Antitrust Law
Alternative Dispute Resolution
Copyright
UPC
Unitary Patent
UPC News
Team
Career
News
Contact
Location
Sprache
DE
EN
News
June 12, 2025
Best Lawyers & Handelsblatt: WR once again in the “Germany's Best Lawyers 2025” ranking
We are delighted that our partners Dr. Mathias Ricker and Dr. Erich Fritsche as well as our founding partner Dr. Michael Wallinger have once again been awarded.
read
June 10, 2025
IAM World’s Leading Patent Professionals 2025: Christian Kirchner and Henning Lülf awarded for the first time
We are pleased that our law firm has once again received multiple awards in this year's IAM Patent 1000: The World's Leading Patent Professionals 2025 ranking.
read
May 02, 2025
Dr. Michael Wallinger appointed to the EPLIT's Board
We are pleased to announce that our founding partner Dr. Michael Wallinger has been appointed to the Board of the European Patent Litigators Association (EPLIT) at this year’s annual meeting.
read
April 11, 2025
BREAKING NEWS: WR is winner of the Switzerland Impact Case of the Year, together with Lenz & Staehelin
As part of the Managing IP Awards 2025 EMEA, our law firm received this award together with our colleagues from the Swiss law firm Lenz & Staehelin.
read
December 09, 2024
Requirement to "adapt" description to allowable claim and to potentially comprehensively rewrite the description may soon be history – but at least for Germany, voluntary amendments may be advantageous
EPO BoA T 56/21 (F. Hoffmann-La Roche AG) of October 4, 2024
read
previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
next
Search form
Search for:
Contact
Legal
Privacy statement